In our cohort, the percentage of γδ T CD8+ cells was significantly higher in CLL patients compared to healthy controls, but no difference in the percentage of γδ T CD4+ was noted (Figure 1C). The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.